ORBIMED ADVISORS LLC - 23 Jan 2026 SCHEDULE 13D/A Report for CORVUS PHARMACEUTICALS, INC. COMMON STOCK (CRVS)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
CORVUS PHARMACEUTICALS, INC. COMMON STOCK
Symbol
CRVS
Shares outstanding
83,583,408 shares
Disclosed Ownership
8,609,091 shares
Ownership
10%
Form type
SCHEDULE 13D/A
Filing time
27 Jan 2026, 20:38:38 UTC
Date of event
23 Jan 2026
Previous filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 10% 8,609,091 0 8,609,091 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP V LLC 10% 8,609,091 0 8,609,091 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001615374